CVS Caremark (CVS) Tops Q3 EPS by 3c; Adjusts FY11 EPS Below Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $93.45 -1.37%
EPS Growth %: +3.1%
Financial Fact:
Interest expense, net: 253M
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: +3.1%
Financial Fact:
Interest expense, net: 253M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
CVS Caremark (NYSE: CVS) reported Q3 EPS of $0.70, $0.03 better than the analyst estimate of $0.67. Revenue for the quarter came in at $26.7 billion versus the consensus estimate of $26.76 billion.
CVS Caremark sees FY2011 EPS of $2.57-$2.61, versus the consensus of $2.78.
CVS Caremark sees FY2011 EPS of $2.57-$2.61, versus the consensus of $2.78.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integra LifeSciences (IART) Tops Q3 EPS by 3c; offers guidance
- Medpace Holdings (MEDP) Tops Q3 EPS by 40c; offers guidance
- Lake Shore Bancorp (LSBK) Tops Q3 EPS by 31c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
